High PD-L1 expression correlates with lymph node metastasis in patients who have undergone radical surgery for primary pulmonary adenocarcinoma
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: As the use of immune checkpoint inhibitors in postoperative adjuvant chemotherapy for patients with programmed death-ligand 1 (PD-L1)-expressing lung cancer has been increasing, it is important to accumulate knowledge on PD-L1. In this study, we retrospectively evaluated PD-L1 expression and the related background characteristics in patients who underwent radical surgery for primary pulmonary adenocarcinoma. Methods: Of 673 non-small cell lung cancer (NSCLC) cases that underwent surgery at Iwate Medical University from January 2017 to December 2022, 453 cases were eligible for study participation. The cases were divided into three groups based on postoperative pathological diagnosis as PD-L1 tumor proportion score (TPS) of less than 1% (negative), 1-49% (low), and 50% or more (high), respectively. Results: gene mutation, and lymph node metastasis. Three-year relapse-free survival (RFS) rates among patients with pulmonary adenocarcinoma expressing higher levels of PD-L1 were significantly worse than those among patients expressing lower PD-L1 levels (P=0.006). In multivariate analysis, lymph node metastasis [odds ratio (OR): 2.14, 95% confidence interval (CI): 1.10-4.16, P=0.02] and SUV-max (OR: 6.08, 95% CI: 2.89-12.8, P<0.001) were independent factors related to high PD-L1 expression in patients who underwent radical surgery for primary pulmonary adenocarcinoma. Cox proportional hazards analysis revealed that both the presence of lymph node metastasis [hazard ratio (HR): 8.61, 95% CI: 2.48-29.86, P<0.001] and higher SUV-max (HR: 4.46, 95% CI: 1.33-14.93, P=0.01) were significantly associated with shorter RFS. Conclusions: High PD-L1 expression correlates with lymph node metastasis and SUV-max in patients who underwent radical surgery for primary pulmonary adenocarcinoma. Lymph node metastasis and high SUV-max were identified as a potential independent risk factor for postoperative recurrence and might be a risk factor for recurrence in the postoperative period.
Source: Journal of Thoracic Disease
Authors: Hidenobu Iwai, Ryuichi Yoshimura, Makoto Tomoyasu, Wataru Shigeeda, Yuka Kaneko, Hironaga Kanno, Ryotaro Endo, Hiroyuki Deguchi, Hajime Saito
Institutions: Iwate Medical University, Akita University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4415731948